PHASE 2 CLINICAL TRIAL OF AC105 (MG/PEG) FOR TREATMENT OF ACUTE SPINAL CORD INJURY (SCI)

$5,350,016FY2012Department of DefenseDOD

Acorda Therapeutics, Inc., Hawthorne NY

Investigators